Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets

v2.4.0.8
Condensed Consolidated Balance Sheets (USD $)
In Thousands, unless otherwise specified
Sep. 30, 2014
Dec. 31, 2013
Assets    
Financing receivables $ 477,933 $ 347,871
Financing receivables held-for-sale 7,241 24,758
Investments held-to-maturity   91,964
Investments available-for-sale 43,447 3,213
Real estate 63,313  
Real estate related intangible assets 18,276  
Securitization assets 6,058 6,144
Cash and cash equivalents 60,913 31,846
Restricted cash and cash equivalents 7,264 49,865
Other intangible assets, net 1,554 1,706
Goodwill 5,942 3,798
Other assets 11,710 10,267
Total Assets 703,651 571,432
Liabilities and Equity    
Accounts payable, dividends payable and accrued expenses 9,418 7,296
Deferred funding obligations 49,727 74,675
Credit facility 212,764 77,114
Asset-backed nonrecourse notes (secured by financing receivables of $105.1 million and $109.5 million, respectively) 93,620 100,081
Other nonrecourse debt (secured by financing receivables of $113.9 million and $156.4 million, respectively) 118,254 159,843
Deferred tax liability 261 1,799
Total Liabilities 484,044 420,808
Equity:    
Preferred stock, par value $0.01 per share, 50,000,000 shares authorized, no shares issued and outstanding 0 0
Common stock, par value $0.01 per share, 450,000,000 shares authorized, 21,774,411 and 15,892,927 shares issued and outstanding, respectively 218 159
Additional paid in capital 233,170 160,120
Retained deficit (19,358) (13,864)
Accumulated other comprehensive income 787 110
Non-controlling interest 4,790 4,099
Total Equity 219,607 150,624
Total Liabilities and Equity $ 703,651 $ 571,432